WEB OF SCIENCE
SCOPUS
Metadata Downloads
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 예경무 | - |
| dc.contributor.author | 신지원 | - |
| dc.contributor.author | 박세광 | - |
| dc.contributor.author | 정지영 | - |
| dc.contributor.author | 김민정 | - |
| dc.date.accessioned | 2025-07-28T18:10:11Z | - |
| dc.date.available | 2025-07-28T18:10:11Z | - |
| dc.identifier.uri | https://scholar.dgist.ac.kr/handle/20.500.11750/58764 | - |
| dc.description.abstract | The present invention relates to a novel anti-c-MPL antibody and a use thereof, and more particularly, to an anti-c-MPL antibody having an effect of increasing platelet production and the number thereof by maturation of megakaryocytes in bone marrow, and a use thereof. The novel anti-c-MPL antibody (2R13) of the present invention has a longer half-life period than conventional therapeutic agents as a polymer material, and has the advantages of low autoantibody production and low immunogenicity as an antibody reagent. In addition, the present invention increases the platelet count in a patient suffering from immune thrombocytopenia that induces a chronic disease or complication, and thus can be used as a therapeutic agent for thrombocytopenia. | - |
| dc.title | Novel anti-c-MPL antibodies and uses thereof | - |
| dc.title.alternative | NOVEL ANTI-C-MPL ANTIBODY AND USE THEREOF | - |
| dc.type | Patent | - |
| dc.publisher.country | CC | - |
| dc.identifier.patentApplicationNumber | 202180089138.1 | - |
| dc.date.application | 2021-11-09 | - |
| dc.identifier.patentRegistrationNumber | 116745321 | - |
| dc.date.registration | 2023-09-12 | - |
| dc.contributor.assignee | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY,INDUSTRY-ACADEMIC COOPERATION FOUNDATION, KOSHIN UNIVERSITY,INJE UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION | - |
| dc.type.iprs | 특허 | - |
